← Leaderboards
Cheng-Wei T Chang
Utah State University
$709,573
Attributed
$709,573
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $139K · FY2005–08$200K$150K$100K$50K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$709,573 · 1
By mechanism
R01$709,573 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Ribosomal Rna”
- Joseph D Puglisi · University Of Alabama At Birmingham$25,228,987
- Chuan He · University Of Chicago$24,305,562
- Alanna Schepartz · Yale University$22,800,000
- Harry F Noller · University Of California Santa Cruz$21,196,055
- Peter Sarnow · Stanford University$19,290,662
- Davide Ruggero · University Of California, San Francisco$19,165,522
Research focus
Ribosomal RnaFluorescenceDrug ResistanceBinding SitesAcidsAminoglycoside ResistanceBaseAmino SugarsAmino AcidsAnthrax DiseaseAnti-Bacterial AgentsAmerican Type Culture CollectionAntibiotic DesignAntibioticsAntimicrobialAmikacinAntifungal AgentsAntineoplastic AgentsAntiviral AgentsAreaBacillus (Bacterium)Bacillus SubtilisBacteriaAntibiotics, Aminoglycoside
Grant awards (5)
Novel Ribostamycins and SAR Study of Ring III Aminosugar$129,292
R01 · FY2008 · AI · contact PI
Novel Ribostamycins and SAR Study of Ring III Aminosugar$131,797
R01 · FY2007 · AI · contact PI
Novel Ribostamycins and SAR Study of Ring III Aminosugar$135,734
R01 · FY2006 · AI · contact PI
Novel Ribostamycins and SAR Study of Ring III Aminosugar$139,000
R01 · FY2005 · AI
Novel Ribostamycins and SAR Study of Ring III Aminosugar$173,750
R01 · FY2004 · AI